Preliminary experiments with primary cells from CLL patients showed that CdA or FdA (1 μM, 48 hours) induces increases in CD20, CD54, and CD95 (not shown). This evidence concerns the gene ICAM1 and B-cell chronic lymphocytic leukemia.